Article
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
N. Engl. J. Med. 2015 Jan 22; 372 (4): 311-9.
Review
Nivolumab for the treatment of classical Hodgkin lymphoma after failure of autologous stem cell transplant and brentuximab.
Expert Rev Anticancer Ther. 2016 Jan 1; 16 (1): 5-12.
Review
A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints.
Int J Mol Sci. 2016 Jul 18; 17 (7).